| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |